The Association for Molecular Pathology released best practice recommendations for improving how complex molecular profiling information is presented to oncologists and other healthcare providers.
Medical Device Network on MSN
Lunit and CellCarta to integrate AI pathology in clinical trials
South Korean company Lunit and Canada-based CellCarta have partnered to integrate digital pathology AI into clinical trials.
Paul N. Staats, MD, a nationally recognized expert in cytopathology and gynecologic pathology, has been appointed Chair of ...
New technologies emerging from the Human Genome Project and the rapidly expanding direct-to-consumer DNA testing have provided a challenging environment for the entry of pharmacogenomics into clinical ...
The Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA), an international organization that advances the use of ...
In the field of pathology, the integration of artificial intelligence (AI) and genomics is paving the way for precision diagnostics that were once thought ...
CHICAGO--(BUSINESS WIRE)--Nucleai, a leading provider of artificial intelligence (AI) solutions for pathology and spatial biology, and Mayo Clinic BioPharma Diagnostics are pleased to announce a ...
In early studies, artificial intelligence (AI) has demonstrated promise toward supporting and augmenting clinician-driven cancer diagnosis and prognosis; an example includes the emergence of digital ...
PagePeek introduces an AI-powered assessment framework for rhinology, auditing imaging and anatomy, molecular mechanisms, ...
Dr. B was not about to wait for his office manager to inform him that yet another clinical practice was sending its pathology work elsewhere. Last year, his group had lost the business of both a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback